Embecta (FRA:JX7) Change In Inventory : €4 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Embecta Change In Inventory?

Embecta's change in inventory for the quarter that ended in Mar. 2024 was €-2 Mil. It means Embecta's inventory increased by €2 Mil from Dec. 2023 to Mar. 2024 .

Embecta's change in inventory for the fiscal year that ended in Sep. 2023 was €-27 Mil. It means Embecta's inventory increased by €27 Mil from Sep. 2022 to Sep. 2023 .

Embecta's Total Inventories for the quarter that ended in Mar. 2024 was €141 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Embecta's Days Inventory for the quarter that ended in Mar. 2024 was 135.31.

Inventory Turnover measures how fast the company turns over its inventory within a year. Embecta's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.67.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Embecta's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.53.

Embecta Change In Inventory Historical Data

The historical data trend for Embecta's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Change In Inventory Chart

Embecta Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

Change In Inventory

8.17

2.97

-15.30

-23.63

-26.99

Embecta Quarterly Data
	Sep19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Inventory	Get a 7-Day Free Trial											-14.94	-10.89	12.84	3.76	-1.93

Embecta Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €4 Mil.

Embecta (FRA:JX7) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Embecta's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	138.88	/	93.656	*	365 / 4
	=	135.31

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Embecta's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	93.656	/	138.88
	=	0.67

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Embecta's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	138.88	/	264.224
	=	0.53

Embecta Change In Inventory Related Terms

Thank you for viewing the detailed overview of Embecta's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Embecta (FRA:JX7) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

EMBC:USA JX7:Germany

Address

300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054

Website

https://www.embecta.com

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Embecta (FRA:JX7) Headlines

No Headlines